These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 34183017)

  • 1. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
    J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
    Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
    Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis.
    Weinger JG; Brosnan CF; Loudig O; Goldberg MF; Macian F; Arnett HA; Prieto AL; Tsiperson V; Shafit-Zagardo B
    J Neuroinflammation; 2011 May; 8():49. PubMed ID: 21569627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
    J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
    Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
    J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis.
    Xiao Y; Xu J; Wang S; Mao C; Jin M; Ning G; Xu J; Zhang Y
    Glia; 2010 Jun; 58(8):932-42. PubMed ID: 20155818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
    Bozoyan L; Dumas A; Patenaude A; Vallières L
    J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
    Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL
    Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
    Yang EJ; Song IS; Song KS
    Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
    Lee E; Chanamara S; Pleasure D; Soulika AM
    J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
    Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
    Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
    Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
    Abdullah A; Maged M; Hairul-Islam M I; Osama I A; Maha H; Manal A; Hamza H
    PLoS One; 2019; 14(4):e0215981. PubMed ID: 31026283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
    Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
    Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.